As of early September 2026, CDC surveillance shows over 3,100 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with roughly 95% outbreak-associated and 94% occurring in unvaccinated or unknown-status individuals. Sustained local transmission across 47 jurisdictions, concentrated in states such as Pennsylvania, South Carolina, and Utah, reflects measles’ high contagiousness via airborne spread and pockets of declining MMR coverage among school-age children. Official data indicate 8% hospitalization rates so far, with CDC reviewing reported deaths while noting zero confirmed fatalities attributed to measles in 2026. Weekly CDC case-count updates and the November Pan American Health Organization review of U.S. elimination status remain key near-term catalysts likely shaping trader assessments of final annual totals.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于2026年美国麻疹病例？
2026年美国麻疹病例？
$7,897,763 交易量
$7,897,763 交易量
2026-12-31
↑3.5千
99%
↑4千
96%
↑4.5千
87%
↑4.5k
86%
↑5千
70%
↑7.5k
15%
↑1万
7%
↑1.25万
2%
$7,897,763 交易量
$7,897,763 交易量
2026-12-31
↑3.5千
$15,573 交易量
99%
↑4千
$240,810 交易量
96%
↑4.5千
$2,930 交易量
87%
↑4.5k
$626 交易量
86%
↑5千
$242,023 交易量
70%
↑7.5k
$194,220 交易量
15%
↑1万
$6,524,884 交易量
7%
↑1.25万
$356,740 交易量
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, CDC surveillance shows over 3,100 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with roughly 95% outbreak-associated and 94% occurring in unvaccinated or unknown-status individuals. Sustained local transmission across 47 jurisdictions, concentrated in states such as Pennsylvania, South Carolina, and Utah, reflects measles’ high contagiousness via airborne spread and pockets of declining MMR coverage among school-age children. Official data indicate 8% hospitalization rates so far, with CDC reviewing reported deaths while noting zero confirmed fatalities attributed to measles in 2026. Weekly CDC case-count updates and the November Pan American Health Organization review of U.S. elimination status remain key near-term catalysts likely shaping trader assessments of final annual totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
市场开放时间： Jun 30, 2026, 2:17 PM ET
交易量
$7,897,763结束日期
2027-01-01市场开放时间
Jun 30, 2026, 2:17 PM ETThis market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, CDC surveillance shows over 3,100 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with roughly 95% outbreak-associated and 94% occurring in unvaccinated or unknown-status individuals. Sustained local transmission across 47 jurisdictions, concentrated in states such as Pennsylvania, South Carolina, and Utah, reflects measles’ high contagiousness via airborne spread and pockets of declining MMR coverage among school-age children. Official data indicate 8% hospitalization rates so far, with CDC reviewing reported deaths while noting zero confirmed fatalities attributed to measles in 2026. Weekly CDC case-count updates and the November Pan American Health Organization review of U.S. elimination status remain key near-term catalysts likely shaping trader assessments of final annual totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
交易量
$7,897,763结束日期
2027-01-01市场开放时间
Jun 30, 2026, 2:17 PM ETAs of early September 2026, CDC surveillance shows over 3,100 confirmed U.S. measles cases—already exceeding the full-year 2025 total of 2,289—with roughly 95% outbreak-associated and 94% occurring in unvaccinated or unknown-status individuals. Sustained local transmission across 47 jurisdictions, concentrated in states such as Pennsylvania, South Carolina, and Utah, reflects measles’ high contagiousness via airborne spread and pockets of declining MMR coverage among school-age children. Official data indicate 8% hospitalization rates so far, with CDC reviewing reported deaths while noting zero confirmed fatalities attributed to measles in 2026. Weekly CDC case-count updates and the November Pan American Health Organization review of U.S. elimination status remain key near-term catalysts likely shaping trader assessments of final annual totals.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题